Patent Case Watch

Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Fed. Cir.

Shire Development, LLC v. Watson Laboratories, Inc. - FL, No. 16-1785 (Fed. Cir. Feb. 10, 2017)

Reversed
Non-Infringement Claim Construction
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 16-1785
Decided
February 10, 2017
Judge
Hughes, J.
Document
Precedential Opinion
Length
10 pages

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Plaintiffs (collectively, Shire) sued Defendants (collec- tively, Watson) for infringing c laims 1 and 3 of U.S. Patent No. 6,773,720 by filing A bbreviated New D rug Application No. 203817 with the Food and Drug Admi n- istration seeking to market a generic version of Shire’s mesalamine drug, LIALDA ®. Because Watson’s ANDA Product does not satisfy the Markush group require ments in claim 1(b), we reverse and remand with instructions to enter judgment of non-infringement.

Download Opinion (PDF)

Source: govinfo.gov USCOURTS collection · retrieved July 23, 2026 · Report an error